AstraZeneca’s submission in U.K. court nothing new, say doctors over
Covishield’s potential to cause blood clots
Related Articles
-
A new method for enzymatic synthesis of potential RNA therapeutics
A team of researchers at IOCB Prague led by Prof. Michal Hocek has developed a novel method for preparing ribonucleic acid (RNA) containing modified bases. Innovative use of engineered DNA polymerases, enzymes commonly used for the synthesis of DNA, led to the development of a general method for the synthesis of RNA modified only at selected sites or even RNA containing various modifications at all nucleotide building blocks.
-
New details emerge of Russia’s potential nuclear space weapon
"The United States has been aware of Russia's pursuit of this sort of capability dating back years, but only recently have we been able to make a more precise assessment of their progress," said Mallory Stewart, State Department assistant secretary for the Bureau of Arms Control, Deterrence, and Stability.
-
Portland’s new professional soccer team unveils name and logo
The soccer team, Portland Hearts of Pine, unveiled its name, logo and motto Saturday morning at Thompson’s Point.